No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
178 |
4. Check minimum number of eventsNone |
178 |
5. Include endpointsNone |
178 |
6. Filter based on genotype QC (FinnGen only) |
178 |
Control definitions (FinnGen only)
- Control exclude
- Q17_CONGEN_MALFO_EYE_EAR_FACE_NECK
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- Q1
- Name in latin
- Malformationes congenitae lentis
Similar endpoints
↥List of similar endpoints to
Congenital lens malformations
based on the number of shared cases.
Similar with more cases:
- Congenital malformations of eye, ear, face and neck
- Congenital malformations, deformations and chromosomal abnormalities
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2183 | 1150 | 1030 |
| Only index persons | 1768 | 928 | 840 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.03 | 0.03 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 10.95 | 12.13 | 9.56 |
| Only index persons | 18.23 | 19.68 | 16.63 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 178 | 114 | 64 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.03 |
| Median age at first event (years) | 34.49 | 34.26 | 34.90 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 163
- Matched controls
- 1630
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q12.0
ICD-10 Finland
Congenital cataract
+∞
199.6
148
*
Z96.1
ICD-10 Finland
Presence of intraocular lens
25.5
44.4
64
40
H27.0
ICD-10 Finland
Aphakia
+∞
32.4
30
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
6.5
20.5
61
137
H26.4
ICD-10 Finland
After-cataract
13.7
20.5
36
33
CKD60
NOMESCO Finland
Anterior vitrectomy
119.6
20.1
21
*
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
5.1
19.4
79
254
74439
ICD-8 Finland
Congenital anomalies of eye, Cataracta NUD
+∞
17.0
16
*
7433A
ICD-9 Finland
Congenital anomalies of eye, Congenital cataract and lens anomalies
+∞
17.0
16
*
H55
ICD-10 Finland
Nystagmus and other irregular eye movements
176.0
15.8
16
*
CJB10
NOMESCO Finland
Laser discission of secondary cataract
10.9
15.5
30
33
ZXA00
NOMESCO Finland
Right side
4.5
14.9
62
194
WX140
NOMESCO Finland
Parabulbar anesthesy
17.9
14.4
22
14
XCD00
NOMESCO Finland
Clinical examination of eye in general anaesthesia
+∞
12.7
12
*
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
140.2
12.6
13
*
114
Kela drug reimbursment
Glaucoma
9.3
12.1
25
31
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
50.7
12.1
14
*
H26.00
ICD-10 Finland
Infantile, juvenile and presenile cataract
+∞
11.6
11
*
TCG10
NOMESCO Finland
Removal of sutures from cornea
128.6
11.6
12
*
S01ED51
ATC
timolol, combinations; ophthalmic
9.7
11.5
23
27
XCW99
NOMESCO Finland
Other investigative procedure of eye
5.6
10.7
32
68
S01ED01
ATC
timolol; ophthalmic
11.8
10.6
19
18
H26.01
ICD-10 Finland
Infantile, juvenile and presenile cataract
117.1
10.5
11
*
Q12.1
ICD-10 Finland
Congenital displaced lens
+∞
10.5
10
*
H33.0
ICD-10 Finland
Retinal detachment with retinal break
25.3
10.4
14
6
ZXD10
NOMESCO Finland
Scheduled procedure
3.0
9.7
75
360
Z3229
NOMESCO Finland
Other healthcare associate professional
5.5
9.6
29
62
H27.1
ICD-10 Finland
Dislocation of lens
+∞
9.5
9
*
CJF10
NOMESCO Finland
Secondary implantation of artificial lens in posterior chamber
+∞
9.5
9
*
3793A
ICD-9 Finland
Other disorders of eye, Aphakia and other disorders of lens[APHAKIA]
+∞
9.5
9
*
H53.0
ICD-10 Finland
Amblyopia ex anopsia
14.8
9.4
15
11
XCK10
NOMESCO Finland
Photography of fundus of eye
5.2
9.3
29
65
ZXA05
NOMESCO Finland
Left side
3.4
9.2
50
186
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
25.7
9.0
12
5
H26.02
ICD-10 Finland
Presenil cataract
11.7
9.0
16
15
CJD20
NOMESCO Finland
Extracapsular cataract extraction with implantation of artificial lens in posterior chamber
94.6
8.5
9
*
ZXA10
NOMESCO Finland
Bilateral
3.4
8.3
44
159
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
18.3
8.2
12
7
ZXE00
NOMESCO Finland
One hour or less
2.6
7.8
76
407
S01EC01
ATC
acetazolamide; systemic
19.5
7.7
11
6
S01AX11
ATC
[U] ofloxacin; ophthalmic
8.3
7.6
16
21
S01EE01
ATC
latanoprost; ophthalmic
6.9
7.2
17
27
ZXD20
NOMESCO Finland
Day surgery
3.4
6.9
34
116
S01EC04
ATC
brinzolamide; ophthalmic
11.6
6.9
12
11
Z01.0
ICD-10 Finland
Examination of eyes and vision
3.1
6.6
37
139
S01EC03
ATC
dorzolamide; ophthalmic
72.5
6.5
7
*
H26.2
ICD-10 Finland
Complicated cataract
27.8
6.3
8
*
37872
ICD-8 Finland
Other diseases of eye, Aphakia artefacta, acquisita
+∞
6.3
6
*
3619
FHL
Other operations in this group, such as corneal refractive surgery
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3018418) pH of Serum or Plasma
57
359
1.86
3.48
5.5
3.7
ph
7.4
7.4
0.33
11
66
(3033658) Prothrombin time (PT) actual/Normal
54
336
1.87
3.42
4.0
4.3
%
95.5
94.7
0.08
54
329
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
37
204
2.03
3.32
2.6
3.0
mmol/l
2.5
2.4
0.16
31
181
(3024561) Albumin [Mass/volume] in Serum or Plasma
73
507
1.75
3.18
6.7
4.6
g/l
35.4
36.8
1.03
65
480
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
30
158
2.08
3.03
2.3
4.7
umol/l
23.5
6.6
0.45
24
136
(3045788) Cell count panel - Pleural fluid
5
6
8.53
2.76
1.4
1.2
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
81
602
1.63
2.62
12.5
7.1
mmol/l
1.2
1.2
0.53
69
508
(3015377) Calcium [Moles/volume] in Serum or Plasma
59
406
1.68
2.57
4.4
3.2
mmol/l
2.4
2.4
0.09
53
359
(3012441) Differential panel - Pleural fluid
5
7
7.31
2.56
1.4
2.0
—
—
—
0
0
(3020717) Zinc [Moles/volume] in Serum or Plasma
6
11
5.60
2.56
1.2
1.1
umol/l
13.9
20.1
—
6
11
(3023368) Bacteria identified in Blood by Culture
46
296
1.75
2.54
5.7
3.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
62
436
1.65
2.47
7.4
6.3
inr
1.0
1.1
1.30
18
139
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
74
548
1.60
2.38
9.8
6.7
mmol/l
1.2
1.2
0.03
69
499
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
20
99
2.15
2.37
4.1
11.0
mmol/l
24.4
25.3
0.50
20
99
(3013290) Carbon dioxide [Partial pressure] in Blood
8
24
3.44
2.21
5.5
3.3
kpa
5.2
5.0
—
8
24
(3027315) Oxygen [Partial pressure] in Blood
8
24
3.44
2.21
5.5
3.3
kpa
9.9
8.8
—
8
24
(1616796) Gas panel - Central venous blood
7
19
3.79
2.17
5.6
3.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
95
758
1.54
2.14
9.3
6.6
e9/l
1.8
1.9
0.84
88
671
(3013115) Eosinophils [#/volume] in Blood
94
749
1.54
2.13
9.0
6.9
e9/l
0.2
0.2
0.13
86
657
(3044941) Cell count panel - Synovial fluid
5
10
5.11
2.08
1.6
1.3
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
96
771
1.53
2.08
9.1
4.6
mmol/l
6.5
6.4
0.05
87
697
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
15
4.10
2.05
1.0
1.3
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
91
725
1.52
2.03
8.4
6.7
e9/l
0.6
0.5
0.76
82
626
(3006315) Basophils [#/volume] in Blood
91
728
1.51
1.98
8.3
6.7
e9/l
0.0
0.0
0.05
82
629
(3013650) Neutrophils [#/volume] in Blood by Automated count
103
850
1.50
1.90
12.1
9.8
e9/l
4.3
4.0
0.41
92
727
(3007853) Bacteria identified in Skin by Aerobe culture
27
162
1.79
1.88
2.1
1.6
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
31
198
1.68
1.75
2.2
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
21
120
1.85
1.71
7.5
9.1
—
—
—
0
0
(3026782) Osmolality of Urine
38
258
1.60
1.70
3.6
2.6
mosm/kgh2o
505.2
553.5
0.70
32
222
(42870588) Differential panel, method unspecified - Blood
63
482
1.48
1.64
9.7
6.6
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
36
244
1.60
1.62
1.2
1.3
iu/ml
55.8
36.3
—
9
72
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
120
1043
1.46
1.56
7.6
6.8
u/l
87.4
80.7
0.35
113
974
(3026008) Bacteria identified in Urine by Culture
53
395
1.49
1.56
2.9
2.7
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
119
1033
1.46
1.56
4.2
4.1
mm/h
10.5
9.4
0.51
111
951
(3018677) aPTT in Platelet poor plasma by Coagulation assay
28
180
1.66
1.55
2.3
2.7
s
30.3
29.6
0.27
28
175
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
22
133
1.75
1.51
2.5
1.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
159
1472
1.75
1.51
16.9
11.5
mg/l
27.3
20.3
1.37
132
1118
(40758558) Short blood count panel - Blood
50
371
1.48
1.50
7.4
7.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
15
80
1.96
1.50
3.9
8.8
mmol/l
23.6
24.2
0.43
15
74
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
22
134
1.73
1.47
2.5
1.8
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
39
276
1.53
1.46
4.0
2.5
e6/l
7.0
5.5
0.46
32
240
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
13
67
2.01
1.42
2.0
1.9
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
50
375
1.46
1.42
4.1
2.7
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
36
252
1.54
1.41
1.6
1.4
nmol/l
22.4
21.8
0.06
30
216
(3030467) Casts [#/volume] in Urine by Automated count
50
377
1.45
1.38
4.1
2.7
e6/l
0.1
0.3
1.89
38
270
(3024928) Oxygen saturation in Venous blood
6
24
2.55
1.31
2.7
9.9
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
16
92
1.81
1.30
2.0
2.7
u/l
11327.1
3405.0
—
9
34
(44806118)
5
18
2.83
1.29
1.8
1.6
—
—
—
0
0
(44790047)
5
18
2.83
1.29
1.8
1.6
—
—
—
0
0
(44790049)
5
18
2.83
1.29
1.8
1.6
—
—
—
0
0
(3028192) IgG subclass 2 [Mass/volume] in Serum
5
18
2.83
1.29
1.2
1.4
g/l
2.2
2.0
—
5
12
(4062490)
5
18
2.83
1.29
1.2
1.4
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
5
18
2.83
1.29
1.2
1.4
g/l
5.0
6.6
—
5
13
(3024139) IgG subclass 3 [Mass/volume] in Serum
5
18
2.83
1.29
1.2
1.4
g/l
0.3
0.3
—
5
12
(44790048)
5
18
2.83
1.29
1.8
1.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
57
448
1.40
1.24
2.3
1.7
pmol/l
99.1
95.6
0.27
24
237
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
126
1127
1.40
1.24
3.9
3.8
pmol/l
14.7
14.6
0.16
116
1024
(40761536) Microorganisms panel - Urine sediment
21
135
1.63
1.18
5.6
3.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
0
35
0.00
1.16
0.0
1.3
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
5
20
2.54
1.16
1.2
2.0
mosm/kgh2o
285.8
281.9
—
5
13
(3019230) Fractional oxyhemoglobin in Venous blood
5
20
2.54
1.16
2.4
11.2
%
73.4
65.1
—
5
20
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
30
2.39
1.13
3.0
3.3
e9/l
3.4
5.0
—
7
30
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
30
2.39
1.13
3.0
3.9
%
58.0
61.3
—
7
30
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
7
30
2.39
1.13
1.0
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
45
345
1.41
1.12
4.6
4.9
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
7
31
2.31
1.11
1.0
2.5
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
33
239
1.47
1.11
2.0
1.6
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
151
1406
1.49
1.09
19.0
12.4
%
39.3
40.4
0.75
113
1131
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
13
75
1.79
1.06
2.0
3.1
ug/l
25.7
5.0
—
8
67
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
22
2.31
1.04
8.4
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
5
22
2.31
1.04
1.0
1.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
82
699
1.32
1.04
11.0
8.9
e9/l
0.0
0.0
0.56
64
560
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
142
1312
1.41
1.03
13.3
10.4
ml/min/173m2
89.3
90.6
0.21
114
1036
(3014111) Lactate [Moles/volume] in Serum or Plasma
17
108
1.63
1.01
6.8
8.9
mmol/l
1.4
1.1
0.84
17
101
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
17
109
1.62
0.97
1.2
1.2
iu/ml
183.6
150.6
—
8
38
(4094501)
0
32
0.00
0.96
0.0
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
52
1.77
0.94
16.2
7.1
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
47
375
1.34
0.92
1.4
1.5
g/l
1.8
2.2
1.39
29
218
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
77
661
1.29
0.90
5.3
6.4
umol/l
21.1
10.7
0.72
72
626
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
43
1.90
0.88
1.5
1.3
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
59
493
1.29
0.84
4.7
3.6
e6/l
118.3
39.2
0.62
43
327
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
39
307
1.35
0.83
2.2
2.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
50
409
1.31
0.83
4.7
3.0
e6/l
15.2
54.3
1.51
38
305
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
131
1213
1.30
0.80
4.8
4.9
mmol/mol
37.9
38.5
0.34
119
1134
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
30
228
1.38
0.80
2.9
2.5
e6/l
0.8
0.7
0.20
17
125
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
34
1.79
0.77
1.7
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
48
395
1.29
0.76
3.5
3.0
mmol/l
8.7
8.1
0.27
39
345
(4306422)
5
25
2.03
0.73
1.0
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
41
332
1.31
0.73
2.0
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
28
214
1.37
0.72
6.5
3.5
ng/l
3104.6
135.3
0.46
22
140
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
40
1.78
0.72
1.0
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
25
188
1.38
0.71
2.0
1.6
nmol/l
1244.9
1245.4
0.00
14
146
(40768804) Tissue Pathology biopsy report
63
542
1.25
0.69
1.7
2.0
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
56
476
1.26
0.68
4.8
3.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
29
363
0.76
0.64
1.7
1.7
mmol/l
1.2
1.4
0.69
22
303
(3028707) Methadone [Presence] in Urine by Screen method
8
51
1.59
0.61
1.9
2.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
0
20
0.00
0.60
0.0
2.1
—
0.1
—
0
15
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
37
445
0.79
0.60
1.5
1.9
—
—
—
0
0
(3000492) Spirometry study
17
123
1.42
0.60
1.2
1.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
0
21
0.00
0.60
0.0
2.1
—
1.3
—
0
7
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
89
1.50
0.60
1.5
1.3
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
22
0.00
0.59
0.0
3.4
—
1.4
—
0
22
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
0
22
0.00
0.59
0.0
2.0
—
587.2
—
0
15
(3050129) First trimester maternal screen panel - Serum or Plasma
5
88
0.56
0.57
2.2
1.3
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
19
142
1.38
0.57
1.5
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
36
1.69
0.57
1.7
1.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
40
1.52
0.52
1.7
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
6
40
1.52
0.52
1.2
1.5
—
0.0
—
0
5
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
40
1.52
0.52
1.7
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
37
310
1.24
0.51
1.9
2.3
mg/l
0.9
1.3
0.59
24
251
(40761511) CBC panel - Blood by Automated count
160
1547
1.34
0.51
15.0
10.1
—
—
—
0
0
(40768443) Skin Pathology biopsy report
10
67
1.52
0.51
1.1
1.1
—
—
—
0
0
(3002256) Pathology report gross observation
20
155
1.33
0.49
1.3
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
47
1.51
0.48
1.3
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
94
869
1.17
0.46
4.1
3.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
26
213
1.26
0.44
3.0
2.7
e6/l
5.0
2.9
0.47
13
113
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
17
131
1.33
0.44
3.8
7.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
31
1.63
0.43
1.6
2.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
8
57
1.42
0.42
1.1
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.3
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.3
—
105.6
—
0
16
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
0
16
0.00
0.41
0.0
3.3
—
4.0
—
0
16
(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
35
300
1.21
0.40
3.1
3.0
umol/l
352.5
5252.4
1.29
30
264
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
18
0.00
0.40
0.0
2.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
0
18
0.00
0.40
0.0
2.1
—
750.8
—
0
8
(3048689) Calprotectin [Mass/mass] in Stool
27
225
1.24
0.40
2.5
2.5
ug/g
322.9
101.5
0.45
20
165
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
140
1344
1.20
0.40
4.9
4.4
mu/l
1.9
1.8
0.09
131
1236
(3038515) Glucose [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
3.7
—
8.0
—
0
19
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
19
0.00
0.39
0.0
1.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
8
111
0.71
0.38
2.1
2.3
—
18.7
—
0
5
(3013139) Helicobacter pylori Ag [Presence] in Stool
10
72
1.41
0.37
1.1
1.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
103
969
1.15
0.37
2.8
3.3
u/l
42.6
40.3
0.13
94
924
(4034850)
6
41
1.48
0.36
7.5
10.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
134
0.73
0.36
1.4
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
6
42
1.44
0.36
1.0
1.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
42
1.44
0.36
1.3
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
6
42
1.44
0.36
1.5
3.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
6
42
1.44
0.36
1.0
1.9
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
6
44
1.38
0.35
1.0
1.2
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
6
45
1.34
0.34
1.3
1.1
—
13.6
—
0
7
(3022621) pH of Urine by Test strip
6
86
0.69
0.34
2.3
1.9
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
28
325
0.84
0.33
2.8
2.5
—
—
—
0
0
(4035726)
13
101
1.31
0.32
1.5
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
36
317
1.17
0.31
3.9
3.2
mg/l
31.1
67.7
1.16
27
205
(3019225) pH of Specimen
8
106
0.74
0.30
16.1
4.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
37
330
1.15
0.28
5.5
4.0
mg/mmol
4.0
11.2
1.67
26
207
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
15
122
1.25
0.28
2.5
3.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
28
244
1.18
0.28
1.3
1.2
u/ml
10.8
7.3
—
10
97
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
33
292
1.16
0.27
4.1
3.5
ng/l
922.8
1110.8
0.20
25
242
(3004119) Hemoglobin [Mass/volume] in Venous blood
8
66
1.22
0.27
9.4
6.3
g/l
125.9
131.5
—
8
66
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
5
73
0.68
0.26
1.6
2.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
5
73
0.68
0.26
2.2
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
21
179
1.20
0.26
1.1
1.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
101
967
1.10
0.23
5.3
4.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
39
1.29
0.23
1.0
1.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
107
1.23
0.22
1.1
1.0
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
48
443
1.11
0.22
3.0
3.4
ng/l
24.2
25.2
0.06
30
270
(3000060) B lymphocytes [#/volume] in Blood
0
11
0.00
0.21
0.0
3.1
—
263.3
—
0
6
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.5
—
24.5
—
0
11
(40768441) Liver Pathology biopsy report
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
10
0.00
0.21
0.0
5.6
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.8
—
812.1
—
0
10
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
4.0
—
1.3
—
0
10
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.2
—
52.1
—
0
10
(3035933) Granulocytes/100 leukocytes in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.7
—
5.1
—
0
12
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(44813793)
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
5
43
1.17
0.21
1.0
1.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
0
13
0.00
0.21
0.0
4.1
—
124.2
—
0
13
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
0
13
0.00
0.21
0.0
2.7
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
47
435
1.11
0.20
2.5
2.0
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.9
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
28
251
1.14
0.20
1.5
1.5
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
49
1.23
0.20
1.5
1.6
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
6
50
1.21
0.20
1.0
1.4
nmol/l
36.2
33.9
—
6
50
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
43
397
1.11
0.20
2.8
2.2
u/l
56.0
56.7
0.04
38
370
(3045414) Leukocytes [Presence] in Urine
6
53
1.14
0.19
2.3
1.4
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
53
1.14
0.19
15.2
3.9
mmol/l
24.4
24.7
—
6
53
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
53
1.14
0.19
2.2
1.8
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
44
408
1.10
0.19
2.5
2.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
7
60
1.17
0.18
13.4
3.2
—
—
—
0
0
(1002224) Polysomnography panel
5
65
0.76
0.17
1.0
1.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
156
1535
1.13
0.16
11.4
9.1
u/l
26.9
26.1
0.22
147
1485
(3025941) Bacteria identified in Stool by Culture
8
71
1.13
0.16
1.3
1.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
72
1.12
0.16
1.1
1.7
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
20
178
1.14
0.16
2.8
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
18
159
1.15
0.16
1.6
1.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
78
1.16
0.15
2.4
1.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
15
131
1.16
0.15
4.8
4.5
%
30.7
32.3
—
7
94
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
7
89
0.78
0.15
1.3
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
247
1.11
0.14
1.1
1.5
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
28
257
1.11
0.14
2.3
1.8
—
—
—
0
0
(3022313) Gas panel - Capillary blood
10
84
1.20
0.14
6.3
6.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
18
161
1.13
0.13
1.2
1.9
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
12
104
1.16
0.12
6.8
5.5
kpa
5.3
5.1
0.24
12
96
(3021601) Nitrite [Presence] in Urine by Test strip
67
697
0.94
0.12
6.4
4.5
estimate
0.0
0.0
0.00
18
160
(40768797) Stomach Pathology biopsy report
19
172
1.12
0.12
1.3
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
21
192
1.11
0.11
4.7
3.8
%
15.8
21.7
—
8
82
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
44
418
1.07
0.11
1.7
1.4
u/ml
0.6
1.6
1.08
11
108
(3009261) Glucose [Presence] in Urine by Test strip
68
704
0.94
0.10
5.0
3.4
estimate
0.0
0.0
0.50
17
156
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
13
145
0.89
0.10
2.6
2.5
ug/l
0.9
0.7
—
6
90
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
48
1.04
0.09
1.2
1.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
130
1320
0.94
0.09
4.2
3.9
mmol/l
1.5
1.5
0.14
117
1240
(3011397) Hemoglobin [Presence] in Urine by Test strip
33
312
1.07
0.09
4.4
3.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
55
1.09
0.09
3.7
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
58
1.04
0.08
10.0
5.9
kpa
8.8
9.1
—
6
53
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
63
0.79
0.08
1.0
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
48
499
0.95
0.08
2.8
2.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
8
76
1.06
0.07
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
7
80
0.87
0.07
4.3
2.3
g/l
64.1
65.3
—
7
75
(3011288) Drugs identified in Urine by Screen method
9
83
1.09
0.07
2.4
2.0
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
68
698
0.96
0.07
5.0
3.3
estimate
0.0
0.0
0.00
18
159
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
28
295
0.94
0.07
2.8
2.3
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
8
92
0.86
0.07
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
193
0.93
0.06
2.4
2.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
130
1316
0.95
0.06
3.9
3.9
mmol/l
5.9
5.7
0.50
118
1215
(40761535) Cells panel - Urine sediment
9
102
0.88
0.06
3.8
3.8
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
22
207
1.07
0.06
1.3
1.4
titre
200.0
458.3
—
6
48
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
63
615
1.04
0.05
4.8
3.9
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
133
1344
0.96
0.05
4.5
4.2
mmol/l
2.8
2.8
0.19
123
1258
(3013512) EKG study
31
323
0.95
0.05
2.6
3.5
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
40
388
1.04
0.04
6.1
3.7
estimate
0.0
0.0
0.00
17
157
(3041096) Erythrocytes [Presence] in Urine by Automated
39
402
0.96
0.04
4.5
2.9
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
53
542
0.97
0.04
5.4
3.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
120
1190
1.03
0.02
3.9
3.6
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
42
429
0.97
0.02
1.6
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
132
1329
0.97
0.02
4.2
3.9
mmol/l
4.7
4.6
0.33
120
1255
(3027008) Opiates [Presence] in Urine
12
113
1.07
0.02
1.6
1.7
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
12
113
1.07
0.02
1.6
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
12
113
1.07
0.02
1.6
1.7
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
12
114
1.06
0.01
1.6
1.7
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
12
126
0.95
0.00
1.7
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
127
1264
1.02
0.00
3.8
3.6
mmol/l
1.3
1.3
0.39
115
1184
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
13
126
1.03
0.00
2.5
3.3
g/l
0.2
0.2
0.34
13
116
(3016879) Cocaine [Presence] in Urine
11
107
1.03
0.00
1.6
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
14
137
1.02
0.00
1.3
1.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
14
145
0.96
0.00
1.4
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
155
0.96
0.00
2.0
1.9
—
—
—
0
0
(4010399)
11
105
1.05
0.00
1.1
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
58
0.86
0.00
6.0
2.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
5
55
0.91
0.00
1.0
2.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
5
54
0.92
0.00
3.2
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
9
96
0.93
0.00
1.2
1.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
6
0.00
0.00
0.0
9.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
0.9
—
0
7
(3002619) Bacteria identified in Specimen by Culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
5
0.00
0.00
0.0
6.0
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
15.7
—
0
7
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
75
0.93
0.00
2.0
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
10.6
—
0
7
(21491868) Cryoglobulin [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
79
1.01
0.00
2.4
1.9
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
3.5
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.9
—
1.0
—
0
8
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
5
0.00
0.00
0.0
2.2
—
151.4
—
0
5
(21494890) Protein electrophoresis panel - 24 hour Urine
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
6
0.00
0.00
0.0
13.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
5
56
0.89
0.00
9.2
4.4
%
61.5
51.8
—
5
56
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
7
74
0.94
0.00
1.4
1.5
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
3.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
5
0.00
0.00
0.0
4.0
—
51.0
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint Q17_CONGEN_LENS_MALFO and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_LENS_MALFO | 1.84 [1.35, 2.5] | < 0.001 |
| Birth year | 0.995 [0.99, 1.0] | 0.26 |
During the follow-up period (1.1.1998 — 31.12.2019), 66 out of 1030 females with Q17_CONGEN_LENS_MALFO died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| Q17_CONGEN_LENS_MALFO | 1.74 [1.29, 2.34] | < 0.001 |
| Birth year | 0.982 [0.97, 0.99] | < 0.001 |
During the follow-up period (1.1.1998 — 31.12.2019), 61 out of 909 males with Q17_CONGEN_LENS_MALFO died.
Mortality risk
Mortality risk for people of age
years, who have Q17_CONGEN_LENS_MALFO.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.179% | 0.298% |
| 5 | 1.2% | 1.783% |
| 10 | 2.636% | 4.544% |
| 15 | 5.309% | 8.245% |
| 20 | 9.297% | 13.429% |
Relationships between endpoints
↥Index endpoint: Q17_CONGEN_LENS_MALFO – Congenital lens malformations
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data